Journal article
Genetic variants are major determinants of CSF antibody levels in multiple sclerosis
Brain, Vol.138(3), pp.632-643
2015
Abstract
Immunological hallmarks of multiple sclerosis include the production of antibodies in the central nervous system, expressed as presence of oligoclonal bands and/or an increased immunoglobulin G index—the level of immunoglobulin G in the cerebrospinal fluid compared to serum. However, the underlying differences between oligoclonal band-positive and -negative patients with multiple sclerosis and reasons for variability in immunoglobulin G index are not known. To identify genetic factors influencing the variation in the antibody levels in the cerebrospinal fluid in multiple sclerosis, we have performed a genome-wide association screen in patients collected from nine countries for two traits, presence or absence of oligoclonal bands (n = 3026) and immunoglobulin G index levels (n = 938), followed by a replication in 3891 additional patients. We replicate previously suggested association signals for oligoclonal band status in the major histocompatibility complex region for the rs9271640*A-rs6457617*G haplotype, correlated with HLA-DRB1*1501, and rs34083746*G, correlated with HLA-DQA1*0301 (P comparing two haplotypes = 8.88 × 10−16). Furthermore, we identify a novel association signal of rs9807334, near the ELAC1/SMAD4 genes, for oligoclonal band status (P = 8.45 × 10−7). The previously reported association of the immunoglobulin heavy chain locus with immunoglobulin G index reaches strong evidence for association in this data set (P = 3.79 × 10−37). We identify two novel associations in the major histocompatibility complex region with immunoglobulin G index: the rs9271640*A-rs6457617*G haplotype (P = 1.59 × 10−22), shared with oligoclonal band status, and an additional independent effect of rs6457617*G (P = 3.68 × 10−6). Variants identified in this study account for up to 2-fold differences in the odds of being oligoclonal band positive and 7.75% of the variation in immunoglobulin G index. Both traits are associated with clinical features of disease such as female gender, age at onset and severity. This is the largest study population so far investigated for the genetic influence on antibody levels in the cerebrospinal fluid in multiple sclerosis, including 6950 patients. We confirm that genetic factors underlie these antibody levels and identify both the major histocompatibility complex and immunoglobulin heavy chain region as major determinants.
Details
- Title
- Genetic variants are major determinants of CSF antibody levels in multiple sclerosis
- Authors/Creators
- A. Goris (Author/Creator) - KU LeuvenI. Pauwels (Author/Creator) - KU LeuvenM.W. Gustavsen (Author/Creator) - Oslo University HospitalB. van Son (Author/Creator) - KU LeuvenK. Hilven (Author/Creator) - KU LeuvenS.D. Bos (Author/Creator) - Oslo University HospitalE.G. Celius (Author/Creator) - Oslo University HospitalP. Berg-Hansen (Author/Creator) - Oslo University HospitalJ. Aarseth (Author/Creator) - Haukeland University HospitalK-M Myhr (Author/Creator) - Haukeland University HospitalS. D'Alfonso (Author/Creator) - Università degli Studi del Piemonte Orientale “Amedeo Avogadro”N. Barizzone (Author/Creator)M.A. Leone (Author/Creator) - Università degli Studi del Piemonte Orientale “Amedeo Avogadro”F. Martinelli Boneschi (Author/Creator)M. Sorosina (Author/Creator) - Vita-Salute San Raffaele UniversityG. Liberatore (Author/Creator) - 10 Department of Neuro-rehabilitation, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, Milan, ItalyI. Kockum (Author/Creator) - Karolinska InstitutetT. Olsson (Author/Creator) - Karolinska InstitutetJ. Hillert (Author/Creator) - Karolinska InstitutetL. Alfredsson (Author/Creator) - Karolinska InstitutetS.K. Bedri (Author/Creator) - Karolinska InstitutetB. Hemmer (Author/Creator) - Technical University of MunichD. Buck (Author/Creator) - Technical University of MunichA. Berthele (Author/Creator) - Technical University of MunichB. Knier (Author/Creator) - Technical University of MunichV. Biberacher (Author/Creator) - Technical University of MunichV. van Pesch (Author/Creator) - UCLouvainC. Sindic (Author/Creator) - UCLouvainA. Bang Oturai (Author/Creator)H.B. Sondergaard (Author/Creator)F. Sellebjerg (Author/Creator) - Danish Multiple Sclerosis CenterP.E.H. Jensen (Author/Creator) - Danish Multiple Sclerosis CenterM. Comabella (Author/Creator) - Vall d'Hebron Institut de RecercaX. Montalban (Author/Creator) - Vall d'Hebron Institut de RecercaJ. Perez-Boza (Author/Creator) - Vall d'Hebron Institut de RecercaS. Malhotra (Author/Creator) - Vall d'Hebron Institut de RecercaJ. Lechner-Scott (Author/Creator) - Hunter Medical Research InstituteS. Broadley (Author/Creator) - Griffith UniversityM. Slee (Author/Creator) - KU LeuvenB. Taylor (Author/Creator) - Menzies Research InstituteA.G. Kermode (Author/Creator) - Murdoch UniversityP-A Gourraud (Author/Creator)S.J. Sawcer (Author/Creator) - University of CambridgeB.K. Andreassen (Author/Creator) - University of OsloB. Dubois (Author/Creator) - KU LeuvenH.F. Harbo (Author/Creator) - Oslo University Hospital
- Publication Details
- Brain, Vol.138(3), pp.632-643
- Publisher
- Oxford University Press
- Identifiers
- 991005544019407891
- Copyright
- © 2015 The Authors
- Murdoch Affiliation
- Institute for Immunology and Infectious Diseases
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
33 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.203 Neuromuscular Disorders
- 1.203.147 Multiple Sclerosis
- Web Of Science research areas
- Clinical Neurology
- Neurosciences
- ESI research areas
- Neuroscience & Behavior